Glucose controversies in the ICU

Journal of Intensive Care Medicine

Volumn 26, Issue 3, 2011, Pages 135-150

  Honiden, Shyoko ^a   Inzucchi, Silvio E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

critical illness; glycemic control; hyperglycemia; hypoglycemia; insulin resistance

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; PATIENT SAFETY; PLEIOTROPY; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; TREATMENT OUTCOME; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79956105777     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610387892     Document Type: Article

References (149)

1. Cely CM, Arora P., Quartin AA, Kett DH, Schein RM Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004 ; 126 (3). 879-887. (Pubitemid 39258045)
2. Krinsley JS Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003 ; 78 (12). 1471-1478. (Pubitemid 37475630)
3. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004 ; 56 (5). 1058-1062. (Pubitemid 38788732)
4. Margulies DR, Hiatt JR, Vinson D. Jr, Shabot MM Relationship of hyperglycemia and severity of illness to neurologic outcome in head injury patients. Am Surg. 1994 ; 60 (6). 387-390. (Pubitemid 24165989)
5. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004 ; 164 (18). 2005-2011. (Pubitemid 39390557)
6. Rovlias A., Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000 ; 46 (2). 335-342 ; discussion 342-333.
7. Capes SE, Hunt D., Malmberg K., Gerstein HC Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000 ; 355 (9206). 773-778. (Pubitemid 30128815)
8. Baird TA, Parsons MW, Phanh T., et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003 ; 34 (9). 2208-2214. (Pubitemid 37099838)
9. Ramos M., Khalpey Z., Lipsitz S., et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008 ; 248 (4). 585-591.
10. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001 ; 345 (19). 1359-1367.
11. Krinsley JS Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004 ; 79 (8). 992-1000. (Pubitemid 39007018)
12. Furnary AP, Gao G., Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003 ; 125 (5). 1007-1021. (Pubitemid 36644877)
13. Grey NJ, Perdrizet GA Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004 ; 10 (suppl 2). 46-52.
14. Laver S., Preston S., Turner D., McKinstry C., Padkin A. Implementing intensive insulin therapy: development and audit of the Bath insulin protocol. Anaesth Intensive Care. 2004 ; 32 (3). 311-316. (Pubitemid 38877791)
15. Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004 ; 38 (7-8). 1123-1129. (Pubitemid 38802146)
16. Taylor BE, Schallom ME, Sona CS, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006 ; 202 (1). 1-9. (Pubitemid 41831468)
17. Van den Berghe G., Wouters PJ, Kesteloot K., Hilleman DE Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006 ; 34 (3). 612-616.
18. Krinsley JS, Jones RL Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006 ; 129 (3). 644-650.
19. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004 ; 10 (1). 77-82.
20. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care. 2006 ; 29 (8). 1955-1962.
21. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004 ; 110 (5). 588-636. (Pubitemid 39036178)
22. Dellinger RP, Carlet JM, Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 ; 32 (3). 858-873. (Pubitemid 38344143)
23. Brunkhorst FM, Engel C., Ragaller M., et al. Practice and perception-a nationwide survey of therapy habits in sepsis. Crit Care Med. 2008 ; 36 (10). 2719-2725.
24. Hirshberg E., Lacroix J., Sward K., Willson D., Morris AH Blood glucose control in critically ill adults and children: a survey on stated practice. Chest. 2008 ; 133 (6). 1328-1335. (Pubitemid 351892987)
25. Devos P., Preiser JC Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU ? Crit Care. 2006 ; 10 (2). 130.
26. Marik PE, Varon J. Intensive insulin therapy in the ICU: is it now time to jump off the bandwagon ? Resuscitation. 2007 ; 74 (1). 191-193. (Pubitemid 46891675)
27. Bellomo R., Egi M. Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc. 2005 ; 80 (12). 1546-1548. (Pubitemid 41747054)
28. Angus DC, Abraham E. Intensive insulin therapy in critical illness. Am J Respir Crit Care Med. 2005 ; 172 (11). 1358-1359.
29. Zander R., Boldt J., Engelmann L., Mertzlufft F., Sirtl C., Stuttmann R. [The design of the VISEP trial. Critical appraisal]. Anaesthesist. 2007 ; 56 (1). 71-77. (Pubitemid 46175183)
30. Brunkhorst FM, Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 ; 358 (2). 125-139.
31. Devos P., Preiser J., Melot C. For the Glucontrol Steering Committee: Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycemia: final results of the Glucontrol study. Intensive Care Medicine. 2007 ; 33: S189.
32. Preiser JC, Devos P., Ruiz-Santana S., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009 ; 35 (10). 1738-1748.
33. Finfer S., Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 ; 360 (13). 1283-1297.
34. Duska F., Andel M. Intensive blood glucose control in acute and prolonged critical illness: endogenous secretion contributes more to plasma insulin than exogenous insulin infusion. Metabolism. 2008 ; 57 (5). 669-671. (Pubitemid 351621919)
35. Lang CH, Dobrescu C., Bagby GJ Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992 ; 130 (1). 43-52.
36. Flores EA, Istfan N., Pomposelli JJ, Blackburn GL, Bistrian BR Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism. 1990 ; 39 (7). 738-743. (Pubitemid 20198268)
37. Khani S., Tayek JA Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (Lond). 2001 ; 101 (6). 739-747. (Pubitemid 33135358)
38. Rodnick KJ, Piper RC, Slot JW, James DE Interaction of insulin and exercise on glucose transport in muscle. Diabetes Care. 1992 ; 15 (11). 1679-1689.
39. Wolfe RR, Herndon DN, Jahoor F., Miyoshi H., Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med. 1987 ; 317 (7). 403-408. (Pubitemid 17131176)
40. Virkamaki A., Yki-Jarvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology. 1994 ; 134 (5). 2072-2078. (Pubitemid 24142945)
41. Vanhorebeek I., De Vos R., Mesotten D., Wouters PJ, De Wolf-Peeters C., Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005 ; 365 (9453). 53-59. (Pubitemid 40082146)
42. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999 ; 67 (2). 352-360 ; discussion 360-352.
43. Perner A., Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med. 2003 ; 29 (4). 642-645. (Pubitemid 36523682)
44. Nielson CP, Hindson DA Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes. 1989 ; 38 (8). 1031-1035. (Pubitemid 20015054)
45. Rassias AJ, Marrin CA, Arruda J., Whalen PK, Beach M., Yeager MP Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg. 1999 ; 88 (5). 1011-1016. (Pubitemid 29211530)
46. Ling PR, Smith RJ, Bistrian BR Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in rats. Crit Care Med. 2005 ; 33 (5). 1084-1089. (Pubitemid 40638183)
47. Iwasaki Y., Kambayashi M., Asai M., Yoshida M., Nigawara T., Hashimoto K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J Diabetes Complications. 2007 ; 21 (1). 56-62. (Pubitemid 44960844)
48. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM Acute hyperglycemia and oxidative stress: direct cause and effect ? Free Radic Biol Med. 2008 ; 44 (7). 1217-1231.
49. Weidig P., McMaster D., Bayraktutan U. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab. 2004 ; 6 (6). 432-441. (Pubitemid 39409794)
50. West IC Radicals and oxidative stress in diabetes. Diabet Med. 2000 ; 17 (3). 171-180. (Pubitemid 30212288)
51. Hagiwara S., Iwasaka H., Hasegawa A., Koga H., Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med. 2008 ; 36 (8). 2407-2413.
52. Ramasamy R., Yan SF, Herold K., Clynes R., Schmidt AM Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 2008 ; 1126: 7-13. (Pubitemid 351589318)
53. He M., Kubo H., Ishizawa K., et al. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2007 ; 293 (6). L1427 - L1436. (Pubitemid 350255025)
54. Zhang H., Tasaka S., Shiraishi Y., et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med. 2008 ; 178 (4). 356-362.
55. Liliensiek B., Weigand MA, Bierhaus A., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004 ; 113 (11). 1641-1650. (Pubitemid 39071688)
56. Uchida T., Shirasawa M., Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006 ; 173 (9). 1008-1015.
57. Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008 ; 63 (12). 1083-1089.
58. Hansen TK, Thiel S., Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003 ; 88 (3). 1082-1088. (Pubitemid 36337759)
59. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect ? J Clin Endocrinol Metab. 2001 ; 86 (7). 3257-3265. (Pubitemid 32674120)
60. Jeschke MG, Klein D., Herndon DN Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004 ; 239 (4). 553-560. (Pubitemid 38372772)
61. Brix-Christensen V., Andersen SK, Andersen R., et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology. 2004 ; 100 (4). 861-870. (Pubitemid 38392573)
62. Jeschke MG, Klein D., Bolder U., Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 2004 ; 145 (9). 4084-4093. (Pubitemid 39120556)
63. Haider DG, Schaller G., Kapiotis S., Maier C., Luger A., Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 2006 ; 49 (8). 1909-1914. (Pubitemid 44025046)
64. Krogh-Madsen R., Moller K., Dela F., Kronborg G., Jauffred S., Pedersen BK Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab. 2004 ; 286 (5). E766 - E772. (Pubitemid 38506948)
65. Mesotten D., Swinnen JV, Vanderhoydonc F., Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004 ; 89 (1). 219-226. (Pubitemid 38183885)
66. Nielsen JS, Larsson A., Brix-Christensen V., Nyengaard JR, Ledet T., Tonnesen E. Endotoxemia-induced lymphocyte apoptosis is augmented by a hyperinsulinemic-euglycemic clamp. Anesthesiology. 2005 ; 102 (4). 768-773. (Pubitemid 40462856)
67. Leffler M., Hrach T., Stuerzl M., Horch RE, Herndon DN, Jeschke MG Insulin attenuates apoptosis and exerts antiinflammatory effects in endotoxemic human macrophages. J Surg Res. 2007 ; 143 (2). 398-406. (Pubitemid 350101570)
68. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005 ; 115 (8). 2277-2286. (Pubitemid 41134169)
69. Landin K., Tengborn L., Chmielewska J., von Schenck H., Smith U. The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man. Thromb Haemost. 1991 ; 65 (2). 130-133.
70. Agus MS, Javid PJ, Ryan DP, Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg. 2004 ; 39 (6). 839-844 ; discussion 839-844. (Pubitemid 38833765)
71. Weekers F., Giulietti AP, Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003 ; 144 (12). 5329-5338. (Pubitemid 37476061)
72. Ellger B., Langouche L., Richir M., et al. Modulation of regional nitric oxide metabolism: blood glucose control or insulin ? Intensive Care Med. 2008 ; 34 (8). 1525-1533.
73. Ben Salem Hachmi L., Bouguerra R., Maatki O., et al. [Hypertension and insulin treatment in type 2 diabetes]. Arch Mal Coeur Vaiss. 2007 ; 100 (8). 664-667. (Pubitemid 47518694)
74. Kanoun F., Ben Amor Z., Zouari B., Ben Khalifa F. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus. Diabetes Metab. 2001 ; 27 (6). 695-700. (Pubitemid 34007865)
75. Sarafidis PA, Bakris GL The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance ? Am J Nephrol. 2007 ; 27 (1). 44-54. (Pubitemid 46364540)
76. Liefvendahl E., Arnqvist HJ Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I. Horm Metab Res. 2008 ; 40 (6). 369-374. (Pubitemid 351967126)
77. Zelobowska K., Gumprecht J., Grzeszczak W. Mitogenic potency of insulin glargine. Endokrynol Pol. 2009 ; 60 (1). 34-39.
78. Zib I., Raskin P. Novel insulin analogues and its mitogenic potential. Diabetes Obes Metab. 2006 ; 8 (6). 611-620. (Pubitemid 44515558)
79. Boden G., Song WW Effects of insulin and free fatty acids on matrix metalloproteinases. Curr Diab Rep. 2008 ; 8 (3). 239-242.
80. Boden G., Song W., Pashko L., Kresge K. In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta. Diabetes. 2008 ; 57 (2). 476-483.
81. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 ; 354 (5). 449-461. (Pubitemid 43200296)
82. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006 ; 55 (11). 3151-3159. (Pubitemid 44923655)
83. De La Rosa Gdel C., Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008 ; 12 (5). R120.
84. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008 ; 36 (12). 3190-3197.
85. Wiener RS, Wiener DC, Larson RJ Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008 ; 300 (8). 933-944.
86. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009 ; 180 (8). 821-827 ; discussion 799-800.
87. Desachy A., Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc. 2008 ; 83 (4). 400-405. (Pubitemid 351536465)
88. Atkin SH, Dasmahapatra A., Jaker MA, Chorost MI, Reddy S. Fingerstick glucose determination in shock. Ann Intern Med. 1991 ; 114 (12). 1020-1024.
89. Sylvain HF, Pokorny ME, English SM, et al. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995 ; 4 (1). 44-48.
90. Kanji S., Buffie J., Hutton B., et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005 ; 33 (12). 2778-2785. (Pubitemid 41816412)
91. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005 ; 127 (5). 1749-1751. (Pubitemid 46218804)
92. Kulkarni A., Saxena M., Price G., O'Leary MJ, Jacques T., Myburgh JA Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med. 2005 ; 31 (1). 142-145. (Pubitemid 40174294)
93. Critchell CD, Savarese V., Callahan A., Aboud C., Jabbour S., Marik P. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007 ; 33 (12). 2079-2084. (Pubitemid 350164561)
94. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 ; 36 (1). 296-327.
95. Finney SJ, Zekveld C., Elia A., Evans TW Glucose control and mortality in critically ill patients. JAMA. 2003 ; 290 (15). 2041-2047. (Pubitemid 37430587)
96. Inzucchi SE, Siegel MD Glucose control in the ICU-how tight is too tight? N Engl J Med. 2009 ; 360 (13). 1346-1349.
97. Moghissi ES, Korytkowski MT, DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009 ; 32 (6). 1119-1131.
98. http://www.survivingsepsis.org/About-the-Campaign/Documents/ SSC%20Statement%20on%20Glucose%20Control%in%20Severe%20Sepsis.pdf. Accessed November 3, 2009.
99. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 ; 345 (19). 1368-1377.
100. Honiden S., Schultz A., Im SA, Nierman DM, Gong MN Early versus late intravenous insulin administration in critically ill patients. Intensive Care Med. 2008 ; 34 (5). 881-887. (Pubitemid 351571187)
101. Kushner M., Nencini P., Reivich M., et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol. 1990 ; 28 (2). 129-135. (Pubitemid 20244513)
102. Kimura K., Iguchi Y., Inoue T., et al. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci. 2007 ; 255 (1-2). 90-94. (Pubitemid 46414023)
103. Salim A., Hadjizacharia P., Dubose J., et al. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg. 2009; 75 (1). 25-29.
104. Jeremitsky E., Omert LA, Dunham CM, Wilberger J., Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005 ; 58 (1). 47-50. (Pubitemid 40221732)
105. Li PA, He QP, Csiszar K., Siesjo BK Does long-term glucose infusion reduce brain damage after transient cerebral ischemia? Brain Res. 2001 ; 912 (2). 203-205. (Pubitemid 32800675)
106. Capes SE, Hunt D., Malmberg K., Pathak P., Gerstein HC Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001 ; 32 (10). 2426-2432. (Pubitemid 32954818)
107. Van den Berghe G., Schoonheydt K., Becx P., Bruyninckx F., Wouters PJ Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005 ; 64 (8). 1348-1353. (Pubitemid 40570499)
108. Bilotta F., Spinelli A., Giovannini F., Doronzio A., Delfini R., Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol. 2007 ; 19 (3). 156-160. (Pubitemid 47012351)
109. Bilotta F., Caramia R., Paoloni FP, Delfini R., Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009 ; 110 (3). 611-619.
110. Bilotta F., Caramia R., Cernak I., et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care. 2008 ; 9 (2). 159-166.
111. Vespa P., Boonyaputthikul R., McArthur DL, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med. 2006 ; 34 (3). 850-856.
112. Kosiborod M., Inzucchi SE, Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009 ; 301 (15). 1556-1564.
113. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007 ; 35 (10). 2262-2267. (Pubitemid 47476221)
114. Vriesendorp TM, DeVries JH, van Santen S., et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006 ; 34 (11). 2714-2718. (Pubitemid 44610935)
115. Vriesendorp TM, van Santen S., DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006 ; 34 (1). 96-101. (Pubitemid 43032385)
116. Suh SW, Hamby AM, Swanson RA Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia. 2007 ; 55 (12). 1280-1286. (Pubitemid 47235369)
117. Egi M., Bellomo R., Stachowski E., et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008 ; 36 (8). 2249-2255.
118. Egi M., Bellomo R., Stachowski E., French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006 ; 105 (2). 244-252. (Pubitemid 44148168)
119. Dossett LA, Cao H., Mowery NT, Dortch MJ, Morris JM Jr, May AK Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg. 2008 ; 74 (8). 679-685 ; discussion 685.
120. Krinsley JS Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008 ; 36 (11). 3008-3013.
121. Risso A., Mercuri F., Quagliaro L., Damante G., Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001 ; 281 (5). E924 - E930.
122. Quagliaro L., Piconi L., Assaloni R., et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005 ; 183 (2). 259-267. (Pubitemid 41579276)
123. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Motz E., Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003 ; 52 (11). 2795-2804. (Pubitemid 37339710)
124. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 ; 295 (14). 1681-1687.
125. Hirsch IB Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther. 2005 ; 7 (5). 780-783. (Pubitemid 41572082)
126. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control ? J Diabetes Complications. 2005 ; 19 (3). 178-181. (Pubitemid 40615551)
127. Van den Berghe G., Wouters PJ, Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003 ; 31 (2). 359-366. (Pubitemid 36232926)
128. Mehta SR, Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute STsegment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005 ; 293 (4). 437-446.
129. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006 ; 55 (4). 1096-1105. (Pubitemid 44100187)
130. Goldberg PA, Sakharova OV, Barrett PW, et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004 ; 18 (6). 690-697. (Pubitemid 40093644)
131. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004 ; 27 (2). 461-467. (Pubitemid 38174072)
132. Kanji S., Singh A., Tierney M., Meggison H., McIntyre L., Hebert PC Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med. 2004 ; 30 (5). 804-810. (Pubitemid 38639470)
133. Chant C., Wilson G., Friedrich JO Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy. 2005 ; 25 (3). 352-359. (Pubitemid 40300322)
134. Collier B., Diaz J. Jr, Forbes R., et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN J Parenter Enteral Nutr. 2005 ; 29 (5). 353-358 ; discussion 359. (Pubitemid 44296702)
135. Braithwaite SS, Edkins R., Macgregor KL, et al. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol Ther. 2006 ; 8 (4). 476-488. (Pubitemid 44735467)
136. Barth MM, Oyen LJ, Warfield KT, et al. Comparison of a nurse initiated insulin infusion protocol for intensive insulin therapy between adult surgical trauma, medical and coronary care intensive care patients. BMC Emerg Med. 2007 ; 7: 14.
137. Tamaki M., Shimizu T., Kanazawa A., et al. Efficacy and safety of modified Yale insulin infusion protocol in Japanese diabetic patients after open-heart surgery. Diabetes Res Clin Pract. 2008 ; 81 (3). 296-302.
138. Goldberg PA, Roussel MG, Inzucchi SE Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectrum. 2005 ; 18 (3). 188-191. (Pubitemid 41665894)
139. Wilson M., Weinreb J., Hoo GW Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care. 2007 ; 30 (4). 1005-1011. (Pubitemid 46556604)
140. Meijering S., Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006 ; 10 (1). R19.
141. Van Herpe T., De Brabanter J., Beullens M., De Moor B., Van den Berghe G. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Crit Care. 2008 ; 12 (1). R24.
142. Vogelzang M., van der Horst IC, Nijsten MW Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004 ; 8 (3). R122 - R127.
143. Goldberg PA, Bozzo JE, Thomas PG, et al. "Glucometrics"- assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006 ; 8 (5). 560-569. (Pubitemid 44946880)
144. Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004 ; 6 (3). 339-347. (Pubitemid 38821619)
145. Price GC, Stevenson K., Walsh TS Evaluation of a continuous glucose monitor in an unselected general intensive care population. Crit Care Resusc. 2008 ; 10 (3). 209-216.
146. De Block C., Manuel-y-Keenoy B., Rogiers P., Jorens P., Van Gaal L. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Curr Diabetes Rev. 2008 ; 4 (3). 234-244.
147. Corstjens AM, Ligtenberg JJ, van der Horst IC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care. 2006 ; 10 (5). R135.
148. Gabbay RA, Sivarajah S. Optical coherence tomography-based continuous noninvasive glucose monitoring in patients with diabetes. Diabetes Technol Ther. 2008 ; 10 (3). 188-193. (Pubitemid 351677592)
149. Torjman MC DN, Goldberg ME Glucose monitoring in acute care: techonologies on the horizon. J Diabetes Sci Technol. 2008 ; 2 (2). 178-181.